Inventor · disambiguated record
James D. Wuest
Also filed as: WUEST JAMES · WUEST JAMES D
10 granted patents·298 citations·filing 1996–2008
90Inventor score
Top patents by PatentIndex Score
10 records- 0195US6872243B2Phase change inks containing gelator additivesXEROX CORP·Filed 2002·Granted Mar 29, 2005·60 cites·109 claims
- 0295US6761758B2Alkylated tetrakis(triaminotriazine) compounds and phase change inks containing sameXEROX CORP·Filed 2002·Granted Jul 13, 2004·62 cites·63 claims
- 0389US6811595B2Guanidinopyrimidinone compounds and phase change inks containing sameXEROX CORP·Filed 2002·Granted Nov 2, 2004·20 cites·63 claims
- 0488US6860928B2Alkylated urea and triaminotriazine compounds and phase change inks containing sameXEROX CORP·Filed 2002·Granted Mar 1, 2005·18 cites·63 claims
- 0579US7157601B2Alkylated urea and triaminotriazine compounds and phase change inks containing sameXEROX CORP·Filed 2006·Granted Jan 2, 2007·2 cites·20 claims
- 0679US7087752B2Alkylated urea and triaminotriazine compounds and phase change inks containing sameXEROX CORP·Filed 2004·Granted Aug 8, 2006·8 cites·13 claims
- 0774US6835833B2Alkylated tetrakis(triaminotriazine) compounds and phase change inks containing sameXEROX CORP·Filed 2004·Granted Dec 28, 2004·10 cites·19 claims
- 0874US5824651AProcess for modification of implant surface with bioactive conjugates for improved integrationUNIV MONTREAL·Filed 1996·Granted Oct 20, 1998·118 cites·19 claims
- 0961US7504502B2Guanidinopyrimidinone compounds and phase change inks containing sameXEROX CORP·Filed 2008·Granted Mar 17, 2009·0 cites·20 claims
- 1053US7371858B2Guanidinopyrimidinone compounds and phase change inks containing sameXEROX CORP·Filed 2004·Granted May 13, 2008·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when James D. Wuest files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →